Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

$30m In Device User Fees Will Go To Real-World Evidence Evaluation System

Sep 08 2016

• By Sue Darcey

Related Content

Industry, US FDA Strike $1Bn Deal After Contentious User-Fee Negotiations

Aug 23 2016

Shuren: FDA Willing to Kick-Start Device Evaluation Program, But Funding Guarantee Needed

May 09 2016

Additional Topics

United States Regulation Post Market Regulation & Studies Medical Device

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.